Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia

PHASE2CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

June 30, 2023

Primary Completion Date

March 18, 2025

Study Completion Date

April 11, 2025

Conditions
High Triglycerides
Interventions
DRUG

NST-1024

400 mg BID

OTHER

Placebo

matched placebo to active arm

Trial Locations (31)

19040

Hatboro Medical Associates/ CCT Research, Hatboro

19111

Mercado Medical Practice / CCT Research, Philadelphia

29379

Velocity Clinical Research - Union, Union

29456

Palmetto Clinical Reserach, Summerville

30047

Lifeline Primary Care/ CCT Research, Lilburn

32132

Velocity Clinical Research, New Smyrna Beach, Edgewater

33014

Floridian Clinical Research, Miami Lakes

33401

Metabolic Research Institute, Inc., West Palm Beach

33756

Clearwater Cardiovascular Consultants, Largo

35487

University of Alabama - Heersink School of Medicine, Birmingham

36526

Alliance for Multispecialty Research, LLC (AMR) - Daphne, Daphne

40292

University of Louisville - UoL Physicians Outpatient Center, Louisville

44122

Velocity Clinical Research - Cleveland, Cleveland

45242

Velocity Clinical Research - Cincinnati, Cincinnati

46383

Velocity Clinical Research, Valparaiso, Valparaiso

47712

Deaconess Clinic - Indiana, Evansville

48098

Troy Internal Medicine, Troy

64116

Clay Platte Family Medicine / CCT Research, Kansas City

67114

Alliance for Multispecialty Research, LLC (AMR) - Newton, Newton

68506

Velocity Clinical Research - Kearney, Lincoln

77401

Apex Mobile Clinical Research, Bellaire

78229

Pinnacle Clinical Research - San Antonio, San Antonio

80012

Lynn Institute of Denver, Aurora

83642

Velocity Clinical Research - Boise, Meridian

84088

Velocity Clinical Research - Salt Lake City, Salt Lake City

84414

Ogden Clinic, Mount View/CCT Research, Pleasant View

85281

Alliance for Multispecialty Research, LLC (AMR) - Phoenix, Tempe

91605

Velocity Clinical Research, North Hollywood, North Hollywood

91942

Velocity Clinical Research, San Diego, La Mesa

92704

Velocity Clinical Research - Costal Heart, Santa Ana

08009

Cenexel HRI, Berlin

Sponsors
All Listed Sponsors
lead

NorthSea Therapeutics B.V.

INDUSTRY

NCT05889156 - Study of the Efficacy and Safety of NST-1024 Versus Placebo in Subjects With Hypertriglyceridemia | Biotech Hunter | Biotech Hunter